BEIGENE LTD's ticker is BGNE and the CUSIP is 07725L102. A total of 249 filers reported holding BEIGENE LTD in Q1 2021. The put-call ratio across all filers is 3.32 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $599,327 | -42.0% | 3,332 | -42.6% | 0.12% | -32.0% |
| Q2 2023 | $1,034,140 | -12.9% | 5,800 | +5.3% | 0.17% | -24.6% |
| Q1 2023 | $1,187,570 | -9.7% | 5,510 | -7.9% | 0.23% | -10.6% |
| Q4 2022 | $1,315,241 | +68.8% | 5,980 | +3.5% | 0.26% | +66.7% |
| Q3 2022 | $779,000 | -5.2% | 5,780 | +13.8% | 0.15% | -7.8% |
| Q2 2022 | $822,000 | -4.9% | 5,080 | +10.9% | 0.17% | +8.5% |
| Q1 2022 | $864,000 | -33.3% | 4,580 | -4.2% | 0.15% | -21.5% |
| Q4 2021 | $1,295,000 | -40.5% | 4,780 | -20.3% | 0.20% | +7.7% |
| Q3 2021 | $2,178,000 | +5.8% | 6,000 | 0.0% | 0.18% | +8.4% |
| Q2 2021 | $2,059,000 | +2.0% | 6,000 | +3.4% | 0.17% | +9.2% |
| Q1 2021 | $2,019,000 | +45.0% | 5,800 | -48.3% | 0.15% | -7.8% |
| Q2 2019 | $1,392,000 | -3.5% | 11,227 | +2.7% | 0.17% | -4.0% |
| Q1 2019 | $1,442,000 | -31.1% | 10,927 | -26.8% | 0.17% | -39.3% |
| Q4 2018 | $2,094,000 | +22.5% | 14,927 | +50.4% | 0.28% | +56.6% |
| Q3 2018 | $1,710,000 | – | 9,927 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 194,838 | $38,098,000 | 49.65% |
| HHLR ADVISORS, LTD. | 5,472,259 | $1,032,068,000 | 21.55% |
| Baker Brothers Advisors | 11,668,897 | $2,200,754,000 | 12.64% |
| Artal Group S.A. | 665,000 | $125,419,000 | 5.25% |
| Boxer Capital, LLC | 500,000 | $94,300,000 | 4.85% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 177,592 | $33,494,000 | 4.64% |
| Old Well Partners, LLC | 32,465 | $6,123,000 | 4.11% |
| E Fund Management (Hong Kong) Co., Ltd. | 27,501 | $5,071,000 | 3.22% |
| Long Corridor Asset Management Ltd | 13,600 | $2,565,000 | 3.12% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $11,398,000 | 2.57% |